# Scott North

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/scott-north/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,146 |
| Field | Prostate Cancer Treatment and Research |
| h-index | 53 |
| i10-index | 134 |
| OpenAlex ID | https://openalex.org/A5061626918 |
| ORCID iD | https://orcid.org/0000-0003-4427-5439 |
| Works | 302 |

## Researcher papers

- [Abiraterone and Increased Survival in Metastatic Prostate Cancer](https://scholariq.org/papers/abiraterone-and-increased-survival-in-metastatic-prostate-cancer/)
- [Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study](https://scholariq.org/papers/prognostic-factors-for-overall-survival-in-patients-with-metastatic-renal-cell/)
- [Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer](https://scholariq.org/papers/enzalutamide-with-standard-first-line-therapy-in-metastatic-prostate-cancer/)
- [Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer](https://scholariq.org/papers/multicenter-assessment-of-neoadjuvant-chemotherapy-for-muscle-invasive-bladder/)

## Researcher topics

- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Radiopharmaceutical Chemistry and Applications](https://scholariq.org/topics/radiopharmaceutical-chemistry-and-applications/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.